Val
—
Gro
—
Qua
—
Mom
—
Sta
—
Cap—
P/S1.13
P/E—
Fwd P/E12.68
PEG1.26
52W— – —
RSI—
Target$452.81 (+10.9%)
Beta1.13
Div0.72%
Loading chart…
RSI (14)
Loading patterns…
HCA Healthcare, Inc., through its subsidiaries, provides health care services in the United States. The company owns, manages, and operates hospitals, ASCs, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, radiation and oncology therapy centers, as well as rehabilitation and physical therapy centers, physician practices, home health agencies, hospices, outpatient physical therapy providers, home and community-based services providers, and various other facilities. Its general and acute care hospitals offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic services, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.
52-Week Range
52W Low
—
52W High
Position in Range
—
RSI (14)
0 · Oversold
RSI 57
Overbought · 100
Signal
Neutral
EMA Price Levels
Volume Analysis
Momentum Dashboard
Trend Strength
Detected Patterns
1Bullish
1Bearish
0Neutral
▲ Double Bottom — Two lows ~$362.80 — bullish reversal confirmed
▼ Bear Flag — Breakdown after -14% pole — bearish continuation
View overlays on the price chart via Chart tab → Pattern Overlays.
EPS — History & Forecast
Estimate
Beat
Miss
Forecast
Loading…
Revenue — History & Forecast
Revenue
Forecast
Loading…
EPS Beat Rate
88%
7/8 quarters
Wall Street Consensus
BUY
BuyHoldSell
Price Target Range
$452.81
+10.9% upside
Low $369
—
High $579
Consensus
Current price
Wall Street Analyst Ratings
| Firm | Rating | Change | Action | Date |
|---|---|---|---|---|
| Goldman Sachs | Buy | — | ↔ Maintain | 2026-07-28 |
| Mizuho | Outperform | — | ↔ Maintain | 2026-07-28 |
| UBS | Buy | — | ↔ Maintain | 2026-07-27 |
| Morgan Stanley | Underweight | — | ↔ Maintain | 2026-07-27 |
| RBC Capital | Outperform | — | ↔ Reiterate | 2026-07-27 |
| Truist Securities | Buy | — | ↔ Maintain | 2026-07-27 |
| Oppenheimer | Outperform | — | ↔ Maintain | 2026-07-27 |
| Keybanc | Overweight | — | ↔ Maintain | 2026-07-27 |
| Baird | Neutral | — | ↔ Maintain | 2026-07-27 |
| Barclays | Equal-Weight | — | ↔ Maintain | 2026-07-27 |
| Wells Fargo | Equal-Weight | — | ↔ Maintain | 2026-07-13 |
| Cantor Fitzgerald | Overweight | — | ↔ Maintain | 2026-07-07 |
| TD Cowen | Buy | — | ↔ Maintain | 2026-06-22 |
| Bernstein | Market Perform | — | ↔ Maintain | 2026-06-04 |
| Stephens & Co. | Overweight | — | ↔ Maintain | 2026-04-27 |
| JP Morgan | Neutral | — | ↔ Maintain | 2026-02-20 |
| Argus Research | Buy | — | ↔ Maintain | 2026-02-06 |
| Jefferies | Buy | — | ↔ Maintain | 2026-01-28 |
| Deutsche Bank | Buy | — | ↔ Maintain | 2026-01-28 |
Goldman Sachs
2026-07-28
Buy
↔ Maintain
Mizuho
2026-07-28
Outperform
↔ Maintain
UBS
2026-07-27
Buy
↔ Maintain
Morgan Stanley
2026-07-27
Underweight
↔ Maintain
RBC Capital
2026-07-27
Outperform
↔ Reiterate
Truist Securities
2026-07-27
Buy
↔ Maintain
Oppenheimer
2026-07-27
Outperform
↔ Maintain
Keybanc
2026-07-27
Overweight
↔ Maintain
Baird
2026-07-27
Neutral
↔ Maintain
Barclays
2026-07-27
Equal-Weight
↔ Maintain
Wells Fargo
2026-07-13
Equal-Weight
↔ Maintain
Cantor Fitzgerald
2026-07-07
Overweight
↔ Maintain
TD Cowen
2026-06-22
Buy
↔ Maintain
Bernstein
2026-06-04
Market Perform
↔ Maintain
Stephens & Co.
2026-04-27
Overweight
↔ Maintain
JP Morgan
2026-02-20
Neutral
↔ Maintain
Argus Research
2026-02-06
Buy
↔ Maintain
Jefferies
2026-01-28
Buy
↔ Maintain
Deutsche Bank
2026-01-28
Buy
↔ Maintain
Profitability
Gross Margin
42.58%TTM
Op. Margin
15.16%TTM
ROE
N/ATTM
Rev. Growth
8.70%YoY
Free Cash Flow
3.62BTTM
FCF Yield
—TTM
Balance Sheet
Debt / Equity
N/AMRQ
Current Ratio
0.99MRQ
Cash
1.01BMRQ
Total Debt
51.55BMRQ
Net Debt
—MRQ
Income
Div. Yield
0.72%TTM
Annual Rate
3.12Fwd
Payout Ratio
10.06%TTM
Dividend History
Payout Ratio (TTM): 10.06%
| Date | Amount / Share | Yield at Payment |
|---|---|---|
| 2026-06-16 | $0.7800 | 0.20% |
| 2026-03-17 | $0.7800 | 0.15% |
| 2025-12-15 | $0.7200 | 0.15% |
| 2025-09-16 | $0.7200 | 0.18% |
| 2025-06-16 | $0.7200 | 0.20% |
| 2025-03-17 | $0.7200 | 0.22% |
| 2024-12-13 | $0.6600 | 0.21% |
| 2024-09-16 | $0.6600 | 0.17% |
| 2024-06-14 | $0.6600 | 0.20% |
| 2024-03-14 | $0.6600 | 0.21% |
| 2023-12-13 | $0.6000 | 0.23% |
| 2023-09-14 | $0.6000 | 0.23% |
| 2023-06-15 | $0.6000 | 0.21% |
| 2023-03-16 | $0.6000 | 0.24% |
| 2022-12-13 | $0.5600 | 0.24% |
| 2022-09-15 | $0.5600 | 0.28% |
| 2022-06-15 | $0.5600 | 0.32% |
| 2022-03-16 | $0.5600 | 0.22% |
| 2021-12-13 | $0.4800 | 0.20% |
| 2021-09-15 | $0.4800 | 0.20% |
| 2021-06-15 | $0.4800 | 0.24% |
| 2021-03-16 | $0.4800 | 0.27% |
| 2020-12-24 | $0.2680 | 0.17% |
| 2020-10-29 | $0.0720 | 0.06% |
| 2020-02-28 | $0.4300 | 0.36% |
| 2019-11-29 | $0.4000 | 0.30% |
| 2019-08-30 | $0.4000 | 0.35% |
| 2019-05-31 | $0.4000 | 0.35% |
| 2019-02-28 | $0.4000 | 0.31% |
| 2018-11-30 | $0.3500 | 0.26% |
| 2018-08-31 | $0.3500 | 0.28% |
| 2018-05-31 | $0.3500 | 0.36% |
| 2018-02-28 | $0.3500 | 0.38% |
| 2012-12-13 | $2.0000 | 7.00% |
| 2012-10-31 | $2.5000 | 10.11% |
| 2012-02-14 | $2.0000 | 9.95% |
How HCA Makes Its Money
Cash Flow Breakdown
Quarterly Metrics
| Quarter | Revenue | Rev YoY | Gross Profit | Op. Income | Net Income | Net YoY | Gross % | Op % | Net % |
|---|
Full Key Statistics
Valuation
| Market Cap | 88.37B |
| Enterprise Value | 144.93B |
| Trailing P/E | 14.03 |
| Forward P/E | 12.68 |
| PEG Ratio (5yr) | 1.26 |
| Price/Sales (ttm) | 1.13 |
| Price/Book (mrq) | -14.41 |
| EV/Revenue | 1.86 |
| EV/EBITDA | 9.20 |
Share Statistics
| Avg Vol (3m) | 1.68M |
| Shares Outstanding | 216.50M |
| Float | 150.16M |
| % Held by Insiders | 16.21% |
| % Held by Institutions | 78.47% |
| Short Ratio | 3.40 |
| Short % of Float | 3.99% |
Profitability
| Gross Margin | 42.58% |
| Operating Margin (ttm) | 15.16% |
| Profit Margin | 8.77% |
| Return on Assets (ttm) | 12.29% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 78.01B |
| Revenue Growth (yoy) | 8.70% |
| Gross Profit (ttm) | 33.22B |
| EBITDA | 15.75B |
| Net Income (ttm) | 6.84B |
| Diluted EPS (ttm) | 29.10 |
| EPS Growth (yoy) | 11.60% |
Balance Sheet
| Total Cash (mrq) | 1.01B |
| Total Debt (mrq) | 51.55B |
| Debt / Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.99 |
| Book Value / Share | -28.32 |
| Operating CF (ttm) | 11.12B |
| Free Cash Flow (ttm) | 3.62B |
Trading & Dividends
| Beta (5Y) | 1.13 |
| 50-Day MA | 387.94 |
| 200-Day MA | 457.48 |
| Fwd Dividend Yield | 75.00% |
| Payout Ratio | 10.06% |
Ownership Breakdown
Institutional 78.47%
Insider 16.21%
Public 5.3%
Short Interest
3.99% of float
Moderate
Institutional 13F Holdings
Famous investors who disclosed a position in HCA in their latest SEC 13F filing.
Loading…
Insider Transactions
| Date | Insider | Role | Transaction | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-07 | MARKS MIKE A | Chief Financial Officer | Stock Gift at price 0.00 per share. | 3,336 | — |
| 2026-04-28 | MICHELSON MICHAEL W | Director | Stock Award(Grant) at price 0.00 per share. | 925 | — |
| 2026-04-28 | CHIDSEY JOHN W | Director | Stock Award(Grant) at price 0.00 per share. | 809 | — |
| 2026-04-28 | DEPARLE NANCY-ANN M. J.D. | Director | Stock Award(Grant) at price 0.00 per share. | 509 | — |
| 2026-04-28 | RILEY WAYNE JOSEPH | Director | Stock Award(Grant) at price 0.00 per share. | 509 | — |
| 2026-04-28 | FRIST THOMAS F III | Director and Beneficial Owner of more than 10% of a Class of Security | Stock Award(Grant) at price 0.00 per share. | 1,041 | — |
| 2026-04-28 | SMITH ANDREA B | Director | Stock Award(Grant) at price 0.00 per share. | 509 | — |
| 2026-04-28 | JOHNSTON HUGH F. | Director | Stock Award(Grant) at price 0.00 per share. | 809 | — |
| 2026-04-28 | FRIST WILLIAM R. | Director and Beneficial Owner of more than 10% of a Class of Security | Stock Award(Grant) at price 0.00 per share. | 809 | — |
| 2026-02-18 | MCALEVEY MICHAEL R. | Officer | Sale at price 533.37 per share. | 1,694 | $903,537 |
| 2026-02-13 | MCALEVEY MICHAEL R. | Officer | Conversion of Exercise of derivative security at price 236.61 per share. | 5,000 | $1,183,050 |
| 2026-02-11 | WYATT CHRISTOPHER F | Officer | Sale at price 505.00 per share. | 4,000 | $2,020,000 |
| 2026-02-11 | BERRES JENNIFER | Officer | Sale at price 503.00 - 526.16 per share. | 8,020 | $4,126,950 |
| 2026-02-10 | BERRES JENNIFER | Officer | Stock Award(Grant) at price 0.00 per share. | 7,116 | — |
| 2026-02-10 | MCALEVEY MICHAEL R. | Officer | Stock Award(Grant) at price 0.00 per share. | 8,372 | — |
| 2026-02-10 | MARKS MIKE A | Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | 5,026 | — |
| 2026-02-10 | ROSSITTO ERICA | Officer | Stock Award(Grant) at price 0.00 per share. | 1,676 | — |
| 2026-02-10 | HAZEN SAMUEL N | Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | 54,934 | — |
| 2026-02-10 | FOSTER JON MARK | Chief Operating Officer | Stock Award(Grant) at price 0.00 per share. | 15,696 | — |
| 2026-02-10 | CUFFE MICHAEL S | Officer | Stock Award(Grant) at price 0.00 per share. | 9,628 | — |
| 2026-02-10 | WYATT CHRISTOPHER F | Officer | Stock Award(Grant) at price 0.00 per share. | 3,350 | — |
| 2026-02-05 | WYATT CHRISTOPHER F | Officer | Conversion of Exercise of derivative security at price 139.06 per share. | 10,670 | $1,483,770 |
| 2026-02-05 | FOSTER JON MARK | Chief Operating Officer | Conversion of Exercise of derivative security at price 139.06 per share. | 29,330 | $4,078,630 |
| 2026-02-03 | CUFFE MICHAEL S | Officer | Stock Gift at price 0.00 per share. | 4,050 | — |
| 2026-02-03 | CUFFE MICHAEL S | Officer | Sale at price 498.09 per share. | 1,500 | $747,135 |
MARKS MIKE A
Chief Financial Officer
Stock Gift at price 0.00 per share.
2026-05-07
3,336 sh
—
MICHELSON MICHAEL W
Director
Stock Award(Grant) at price 0.00 per share.
2026-04-28
925 sh
—
CHIDSEY JOHN W
Director
Stock Award(Grant) at price 0.00 per share.
2026-04-28
809 sh
—
DEPARLE NANCY-ANN M. J.D.
Director
Stock Award(Grant) at price 0.00 per share.
2026-04-28
509 sh
—
RILEY WAYNE JOSEPH
Director
Stock Award(Grant) at price 0.00 per share.
2026-04-28
509 sh
—
FRIST THOMAS F III
Director and Beneficial Owner of more than 10% of a Class of Security
Stock Award(Grant) at price 0.00 per share.
2026-04-28
1,041 sh
—
SMITH ANDREA B
Director
Stock Award(Grant) at price 0.00 per share.
2026-04-28
509 sh
—
JOHNSTON HUGH F.
Director
Stock Award(Grant) at price 0.00 per share.
2026-04-28
809 sh
—
FRIST WILLIAM R.
Director and Beneficial Owner of more than 10% of a Class of Security
Stock Award(Grant) at price 0.00 per share.
2026-04-28
809 sh
—
MCALEVEY MICHAEL R.
Officer
Sale at price 533.37 per share.
2026-02-18
1,694 sh
$903,537
MCALEVEY MICHAEL R.
Officer
Conversion of Exercise of derivative security at price 236.61 per share.
2026-02-13
5,000 sh
$1,183,050
WYATT CHRISTOPHER F
Officer
Sale at price 505.00 per share.
2026-02-11
4,000 sh
$2,020,000
BERRES JENNIFER
Officer
Sale at price 503.00 - 526.16 per share.
2026-02-11
8,020 sh
$4,126,950
BERRES JENNIFER
Officer
Stock Award(Grant) at price 0.00 per share.
2026-02-10
7,116 sh
—
MCALEVEY MICHAEL R.
Officer
Stock Award(Grant) at price 0.00 per share.
2026-02-10
8,372 sh
—
MARKS MIKE A
Chief Financial Officer
Stock Award(Grant) at price 0.00 per share.
2026-02-10
5,026 sh
—
ROSSITTO ERICA
Officer
Stock Award(Grant) at price 0.00 per share.
2026-02-10
1,676 sh
—
HAZEN SAMUEL N
Chief Executive Officer
Stock Award(Grant) at price 0.00 per share.
2026-02-10
54,934 sh
—
FOSTER JON MARK
Chief Operating Officer
Stock Award(Grant) at price 0.00 per share.
2026-02-10
15,696 sh
—
CUFFE MICHAEL S
Officer
Stock Award(Grant) at price 0.00 per share.
2026-02-10
9,628 sh
—
WYATT CHRISTOPHER F
Officer
Stock Award(Grant) at price 0.00 per share.
2026-02-10
3,350 sh
—
WYATT CHRISTOPHER F
Officer
Conversion of Exercise of derivative security at price 139.06 per share.
2026-02-05
10,670 sh
$1,483,770
FOSTER JON MARK
Chief Operating Officer
Conversion of Exercise of derivative security at price 139.06 per share.
2026-02-05
29,330 sh
$4,078,630
CUFFE MICHAEL S
Officer
Stock Gift at price 0.00 per share.
2026-02-03
4,050 sh
—
CUFFE MICHAEL S
Officer
Sale at price 498.09 per share.
2026-02-03
1,500 sh
$747,135